YUESAI BIOTECHNOLOGY

Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs.

#Financial #More

YUESAI BIOTECHNOLOGY

Industry:
Biotechnology

Founded:
1970

Address:
Pudong, Shandong, China

Country:
China

Total Employee:
11+

Status:
Active

Total Funding:
200 M CNY


Investors List

kunlun_image

KUNLUN

KUNLUN investment in Seed Round - Yuesai Biotechnology

tf-capital_image

TF Capital

TF Capital investment in Seed Round - Yuesai Biotechnology

fosun-pharmaceutical_image

Fosun Pharma

Fosun Pharma investment in Seed Round - Yuesai Biotechnology

ruihua-venture-capital_image

Ruihua Venture Capital

Ruihua Venture Capital investment in Seed Round - Yuesai Biotechnology

cdh-investments_image

CDH Investments

CDH Investments investment in Seed Round - Yuesai Biotechnology

hillhouse-capital_image

Hillhouse Capital Group

Hillhouse Capital Group investment in Seed Round - Yuesai Biotechnology

sherpa-venture-capital_image

Sherpa Venture Capital

Sherpa Venture Capital investment in Seed Round - Yuesai Biotechnology

More informations about "Yuesai Biotechnology" on Search Engine

Yuesai Biotechnology - Crunchbase Company Profile & Funding

Yuesai Biotechnology is a cell therapy drug developer that uses human pluripotent stem cell technology. Yuesai Biotechnology develops stem cell therapy for โ€ฆSee details»

Yuesai Biotechnology Company Profile: Valuation & Investors

Aug 25, 2021 Yuesai Biotechnology General Information. Description. Developer of cellular therapy based on human pluripotent stem cells. The company develops stem cell therapy, committing to cure neurodegenerative diseases, rare diseases and tumors. Contact Information. Ownership Status. Privately Held (backing)See details»

Yuesai biology obtained nearly 200 million yuan of pre-A round of ...

Mar 14, 2022 Healthcare Mar 14, 2022 09:38 AM (GMT+8) · EqualOcean On March 14, Shanghai yuesai Biotechnology Co., Ltd. (hereinafter referred to as "yuesai biology"), a โ€ฆSee details»

Yuesai - L'Oréal Group - L'Oréal Luxe Division

Yuesai believes in the powerful properties and wisdom of TCM (Traditional Chinese Medicine) for both beauty & wellness. Taking the most precious TCM, like the finest Ganoderma from Huoshan, Cordyceps from Qinghai, โ€ฆSee details»

Shanghai Yuesai Biotechnology Co., Ltd. announced that it has โ€ฆ

May 25, 2023 Shanghai Yuesai Biotechnology Co., Ltd. announced that it has received $31,500,000 in a round of funding co-led by ACME, LLC and CDH Investment โ€ฆSee details»

Yuesai Biology | VentureRadar

Yuesai Biology is an enterprise focusing on the development of a new generation of cell therapy drugs based on human pluripotent stem cell technology. It is committed to technology research and product development in the field of stem cell therapy. Its R&D pipeline covers neurodegenerative diseases and rare diseases and tumors.See details»

Yuesai Biotechnology - Updates, News, Events, Signals & Triggers

Edit Recent News & Activity Section. Funding Round โ€ข Mar 14, 2022. Yuesai Biotechnology raised CN¥200,000,000 / Seed from CDH Investments and 6 other investorsSee details»

Another Breakthrough For The Group In China: After Mininurse, โ€ฆ

Find all the Press Releases from L'Oréal Groupe about Group: Another Breakthrough For The Group In China: After Mininurse, Lโ€™Oreal Acquires Yue-Sai.See details»

Seed Round - Yuesai Biotechnology - 2022-03-14

Mar 14, 2022 Yuesai Biotechnology raised $31419370 on 2022-03-14 in Seed Round. Start Free TrialSee details»

Suozhi Biotechnology (Zhejiang) Co., Ltd. inc. | VentureRadar

Nuwacell Biotechnologies China n/a Nuwacell Biotechnology CO., Ltd (Anhui, P.R. China) was founded by Dr. Junying Yu, a world-famous scientist and one of the inventors of human induced pluripotent stem cells (hiPSC). Nuwacell is a high-tech enterprise focusing on hiPSC research and clinical transformation, and is committed to becoming the leading โ€ฆSee details»

Yuesai Biotechnology - Headquarter Location, Corporate Office โ€ฆ

Yuesai Biotechnology is Drug Discovery in China that focus on developer business. Founded in 2021. They cover business area such as developer, cellular therapy, human โ€ฆSee details»

Yuesai Biotechnology has 1 Funding Round from 7 Investors

Yuesai Biotechnology has 1 Funding Round from 7 Investors. Save Search . Companies Contacts Investors Funding Rounds Acquisitions People Events Schools Hubs Saved . Organization Name . Add Funding Rounds filter . includes any. Operator.See details»

Fosun Pharma - Funding, Financials, Valuation & Investors

May 18, 2023 Highlights Lead Investments 15 Investments 31 Exits 11 Funding Fosun Pharma is registered under the ticker HKG:2196 . Fosun Pharma has made 31 investments. Their most recent investment was on โ€ฆSee details»

Shanghai Yuesai Biotechnology | Evaluate

April 26, 2023 Tecentriq runs out of luck in triple-negative breast cancer Roche puts on a brave face as its anti-PD-L1 drug fails yet another TNBC study, this time in the adjuvant โ€ฆSee details»

The Second Generation of Yuesai Gold-plated Bottle Essence

May 9, 2022 As a gilded CP, YUESAI and Li Jiaqi jointly created a new YUESAI gilded liquid foundation. This is the brand's first high-coverage skincare foundation. Selected โ€ฆSee details»

National Center for Biotechnology Information

Before sharing sensitive information, make sure you're on a federal government site. The site is secure. ... The National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic information.See details»

Biotechnology | Definition, Examples, & Applications | Britannica

Biotechnology, the use of biology to solve problems and make useful products. The most prominent area of biotechnology is the production of therapeutic proteins and other drugs through genetic engineering. โ€ฆSee details»

Yue-Sai Cosmetics Company Profile: Acquisition & Investors

Yue-Sai Cosmetics General Information. Description. Manufacturer and distributor of cosmetics and beauty products. The company's products include skin care, facial care, eye care, lip care and makeup products. Contact Information. site. www.yuesai.com. Ownership Status. Acquired/MergedSee details»

YUESAI Rejuvenate Cordyceps Personalized Serum - Fine โ€ฆ

Sep 15, 2019 YUESAI Rejuvenate Cordyceps Personalized Serum - Fine ingredients explained: Aqua, Propylene Glycol, Bifida Ferment Lysate, Glycerin, Dipropylene Glycol, Propanediol, PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin, Hydroxypropyl Tetrahydropyrantriol, Salicylic Acid, Capryloyl Glycine, Bis-PEG-18 Methyl Ether โ€ฆSee details»

CDH Investments - Recent News & Activity

Apr 7, 2023 Yuesai Biotechnology raised CN¥200,000,000 / Seed from CDH Investments and 6 other investors . Discover more funding rounds . ... Mission Information โ€ฆSee details»